Riskpilot← Back to searchSign inGet full accessdeCure Stockholm AB
ABActiveOrg 5569736977Bysistorget 4Wholesale of perfume and cosmetics · NACE 4645Est. 20140 employees
Revenue 2024
SEK 74K
-50% vs 2023
EBITDA margin
-67.6%
+55% vs 2023
Equity ratio
81.1%
Financial strength
Net profit 2024
SEK -51K
-325% vs 2023
| Revenue | SEK 74K | -50% |
| EBITDA | SEK -50K | +55% |
| Net profit | SEK -51K | -325% |
| Total assets | SEK 302K | -12% |
| Equity | SEK 245K | -18% |
| Employees | 0 | — |
Legal name
deCure Stockholm AB
Org number
5569736977
Legal form
Aktiebolag
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
4 juni 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultation och utbildning inom ekonomi, marknad, försäljning, logistik och administration. Bedriva försäljning och distribution av hud och kroppsvårdsprodukter, hälsoprodukter. kläder, livsstilsprodukter och kemisk tekniska produkter samt ävensom idka därmed förenlig verksamhet.
Address
Bysistorget 4
Email
peter@decure.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | — | 542 | 458 | 148 | 74 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 0 | 89 | 185 | −112 | −50 |
| Depreciation & amort. | — | −0 | −13 | −13 | −13 |
| EBIT | 0 | 89 | 172 | −125 | −63 |
| Net financials | — | — | −1 | −1 | — |
| Profit before tax | 0 | 52 | 127 | −12 | −51 |
| Tax | — | −22 | −28 | −0 | −0 |
| Net profit | — | 30 | 99 | −12 | −51 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | — | 442 | 550 | 344 | 302 |
| Equity | — | 210 | 308 | 297 | 245 |
| Long-term debt | — | 90 | 48 | 8 | 56 |
| Short-term debt | — | 61 | 68 | 28 | 0 |
| Total debt | — | 151 | 116 | 36 | 56 |
EBITDA margin
-67.6%
This company
15.8%
Market median
-528% vs market
20202024
Equity ratio
81.1%
This company
38.2%
Market median
+112% vs market
20202024
Return on equity
-20.8%
This company
18.4%
Market median
-213% vs market
20202024
Net profit margin
-68.9%
This company
8.1%
Market median
-951% vs market
20202024
Asset turnover
0.25×
This company
1.12×
Market median
-78% vs market
20202024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of deCure Stockholm AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Peter Ternström | Board of Directors | 0 companies |
| Annika Helena Paula Ternström | Deputy Board Member | 0 companies |